Integrative characterization of human hepatocellular carcinoma-derived organoids and their HBV-associated biology

Background

Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies and is characterized by a high degree of heterogeneity. However, HCC treatment remains difficult, highlighting the need to better define molecular subgroups of HCC and understand their potential relationships with therapeutic response.

Methods